28-Oct-2019 - Université de Montréal

Cancer treatment: A researcher makes breakthrough immunotherapy discovery

Dr Christopher E. Rudd, a researcher at the Centre de recherche de l'Hôpital Maisonneuve-Rosemont (CR-HMR) and Université de Montréal, has discovered a new cell therapy approach that boosts the immune response of T lymphocytes to malignant tumours.

"Our work has identified a new T-cell protein that interacts with the key receptor that detects and responds to cancer antigens," says Prof. Rudd. "We have used those findings to develop a new form of immunotherapy in which hyperactivation of T cells enables them to penetrate and attack tumours. This discovery demonstrates that modulation of the identified protein can activate the immune system and lead to destruction of the cancer cells."

To date, the effectiveness of the new form of immunotherapy against leukemia and some skin cancers has been demonstrated in animals. The next stage will be clinical trials with human subjects.

"This discovery is a scientific breakthrough that will have significantly enhance the immune system's effectiveness in eliminating cancer cells," says Dr. Denis-Claude Roy, scientific and medical director of the Center of Excellence in Cellular Therapy and CR-HMR.

Eventually, this approach could also improve the effectiveness of the new CAR‑T cell therapy currently being used at Hôpital Maisonneuve-Rosemont.

Facts, background information, dossiers
More about Université de Montréal
  • News

    Can gut infection trigger Parkinson's disease?

    A new study by Montreal scientists published in Nature demonstrates that a gut infection can lead to a pathology resembling Parkinson's disease (PD) in a mouse model lacking a gene linked to the human disease. This discovery extends recent work by the same group suggesting that PD has a maj ... more

    Detecting bacteria in space

    Scientists at Université de Montréal and McGill University have pioneered and tested a new genomic methodology which reveals a complex bacterial ecosystem at work on the International Space Station. Their study is published today in Environmental Microbiology. Until now, relatively little w ... more

    Discovery of a protein linked to metastasis in breast cancer

    Jean-François Côté, a researcher at the Montreal Clinical Research Institute (IRCM) and professor at Université de Montréal's Faculty of Medicine, studies metastasis, the leading cause of cancer-related death. Recently, his team uncovered a protein that, once deactivated, could prevent the ... more